Identification of cerebrospinal fluid biomarkers for parkinsonism using a proteomics approach
Abstract The aim of our study was to investigate cerebrospinal fluid (CSF) tryptic peptide profiles as potential diagnostic biomarkers for the discrimination of parkinsonian disorders. CSF samples were collected from individuals with parkinsonism, who had an uncertain diagnosis at the time of inclus...
Enregistré dans:
Auteurs principaux: | Tainá M. Marques, Anouke van Rumund, Iris Kersten, Ilona B. Bruinsma, Hans J.C.T. Wessels, Jolein Gloerich, Charlotte Kaffa, Rianne A. J. Esselink, Bastiaan R. Bloem, H. Bea Kuiperij, Marcel M. Verbeek |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/20d7ff2906c34b81b81ceb6c702ca96f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase
par: Anouke van Rumund, et autres
Publié: (2021) -
Correction to: Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy
par: Anna M. De Kort, et autres
Publié: (2021) -
Quantitative Proteomics of Cerebrospinal Fluid in Paediatric Pneumococcal Meningitis
par: Guadalupe Gómez-Baena, et autres
Publié: (2017) -
Cerebrospinal fluid glucose and lactate: age-specific reference values and implications for clinical practice.
par: Wilhelmina G Leen, et autres
Publié: (2012) -
Cerebrospinal fluid proteome shows disrupted neuronal development in multiple sclerosis
par: Ellen F. Mosleth, et autres
Publié: (2021)